Canada markets open in 1 hour 34 minutes

Agile Therapeutics, Inc. (AGRX)

OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD
Add to watchlist
0.3170-0.0229 (-6.74%)
At close: 01:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.3399
Open0.3400
Bid0.3171 x 0
Ask0.3400 x 0
Day's Range0.3170 - 0.3400
52 Week Range0.2000 - 3.4000
Volume1,452
Avg. Volume133,053
Market Cap2.173M
Beta (5Y Monthly)1.22
PE Ratio (TTM)N/A
EPS (TTM)-0.5200
Earnings DateAug 07, 2024 - Aug 12, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

    First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2024 and provided a corporate update. “We are excited about the start of 2024, which saw a rebound in demand, factory sales and net sales in th

  • Insider Monkey

    Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript

    Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript March 28, 2024 Agile Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.46 EPS, expectations were $-0.92. AGRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome […]

  • Thomson Reuters StreetEvents

    Q4 2023 Agile Therapeutics Inc Earnings Call

    Q4 2023 Agile Therapeutics Inc Earnings Call